Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 36,600 shares, a decrease of 21.8% from the November 15th total of 46,800 shares. Based on an average daily trading volume, of 518,100 shares, the short-interest ratio is presently 0.1 days. Approximately 5.8% of the company’s shares are sold short.

Autonomix Medical Stock Up 1.3 %

Shares of Autonomix Medical stock traded up $0.04 during trading on Friday, hitting $3.19. The company’s stock had a trading volume of 50,521 shares, compared to its average volume of 222,710. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26. The company has a fifty day simple moving average of $9.37 and a two-hundred day simple moving average of $15.98. The company has a market capitalization of $3.67 million and a PE ratio of -0.20. Autonomix Medical has a 52 week low of $3.01 and a 52 week high of $152.00.

Analyst Upgrades and Downgrades

Separately, LADENBURG THALM/SH SH began coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 target price for the company.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.